ペプチド治療薬市場は、2023年から2028年の間に178億5,000万米ドル成長し、予測期間中に10.03%のCAGRで加速すると予測されています。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、感染症の蔓延の増加、有利な償還ポリシーの利用可能性、および半減期の延長された薬剤によって推進されています。
この調査では、今後数年間のペプチド治療薬市場の成長を牽引する主な理由の1つとして、研究開発のコラボレーションが挙げられています。また、ペプチド治療薬の強力なパイプラインと新しい技術の出現により、市場でかなりの需要が生まれるでしょう。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ billion)
Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Peptide Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Peptide Therapeutics Market 2018 - 2022 ($ billion)
4.2 Route of Administration segment analysis 2018 - 2022
Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Route of Administration
6.1 Market segments
Chart on Route of Administration - Market share 2023-2028 (%)
Data Table on Route of Administration - Market share 2023-2028 (%)
6.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
6.3 Parenteral - Market size and forecast 2023-2028
Chart on Parenteral - Market size and forecast 2023-2028 ($ billion)
Data Table on Parenteral - Market size and forecast 2023-2028 ($ billion)
Chart on Parenteral - Year-over-year growth 2023-2028 (%)
Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
6.4 Oral - Market size and forecast 2023-2028
Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Chart on Oral - Year-over-year growth 2023-2028 (%)
Data Table on Oral - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ billion)
Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ billion)
Data Table on Market opportunity by Route of Administration ($ billion)
7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share by geography 2023-2028 (%)
Data Table on Market share by geography 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ billion)
Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ billion)
Data Table on US - Market size and forecast 2023-2028 ($ billion)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ billion)
Data Table on China - Market size and forecast 2023-2028 ($ billion)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
8.10 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ billion)
Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.11 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity by geography
Market opportunity by geography ($ billion)
Data Tables on Market opportunity by geography ($ billion)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
11.4 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
11.5 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
11.6 Ever Pharma
Ever Pharma - Overview
Ever Pharma - Product / Service
Ever Pharma - Key offerings
11.7 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
11.8 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
11.9 Novo Nordisk AS
Novo Nordisk AS - Overview
Novo Nordisk AS - Business segments
Novo Nordisk AS - Key news
Novo Nordisk AS - Key offerings
Novo Nordisk AS - Segment focus
11.10 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
11.11 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
11.12 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
11.13 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Parent Market
Exhibits10: Data Table on - Parent Market
Exhibits11: Market characteristics analysis
Exhibits12: Value Chain Analysis
Exhibits13: Offerings of companies included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Historic Market Size - Data Table on Global Peptide Therapeutics Market 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits31: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Parenteral - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Parenteral - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Route of Administration ($ billion)
Exhibits47: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibits48: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits49: Chart on Market share by geography 2023-2028 (%)
Exhibits50: Data Table on Market share by geography 2023-2028 (%)
Exhibits51: Chart on Geographic comparison
Exhibits52: Data Table on Geographic comparison
Exhibits53: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits55: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits56: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits57: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits59: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits60: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits61: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits63: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits66: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits67: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits70: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits71: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits74: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits75: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits78: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits79: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits82: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits83: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits86: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits87: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits89: Market opportunity by geography ($ billion)
Exhibits90: Data Tables on Market opportunity by geography ($ billion)
Exhibits91: Impact of drivers and challenges in 2023 and 2028
Exhibits92: Overview on criticality of inputs and factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Companies covered
Exhibits96: Matrix on companies position and classification
Exhibits97: Amgen Inc. - Overview
Exhibits98: Amgen Inc. - Product / Service
Exhibits99: Amgen Inc. - Key news
Exhibits100: Amgen Inc. - Key offerings
Exhibits101: AstraZeneca Plc - Overview
Exhibits102: AstraZeneca Plc - Product / Service
Exhibits103: AstraZeneca Plc - Key news
Exhibits104: AstraZeneca Plc - Key offerings
Exhibits105: Eli Lilly and Co. - Overview
Exhibits106: Eli Lilly and Co. - Product / Service
Exhibits107: Eli Lilly and Co. - Key news
Exhibits108: Eli Lilly and Co. - Key offerings
Exhibits109: Ever Pharma - Overview
Exhibits110: Ever Pharma - Product / Service
Exhibits111: Ever Pharma - Key offerings
Exhibits112: GlaxoSmithKline Plc - Overview
Exhibits113: GlaxoSmithKline Plc - Business segments
Exhibits114: GlaxoSmithKline Plc - Key news
Exhibits115: GlaxoSmithKline Plc - Key offerings
Exhibits116: GlaxoSmithKline Plc - Segment focus
Exhibits117: Novartis AG - Overview
Exhibits118: Novartis AG - Business segments
Exhibits119: Novartis AG - Key news
Exhibits120: Novartis AG - Key offerings
Exhibits121: Novartis AG - Segment focus
Exhibits122: Novo Nordisk AS - Overview
Exhibits123: Novo Nordisk AS - Business segments
Exhibits124: Novo Nordisk AS - Key news
Exhibits125: Novo Nordisk AS - Key offerings
Exhibits126: Novo Nordisk AS - Segment focus
Exhibits127: Pfizer Inc. - Overview
Exhibits128: Pfizer Inc. - Product / Service
Exhibits129: Pfizer Inc. - Key news
Exhibits130: Pfizer Inc. - Key offerings
Exhibits131: Sanofi SA - Overview
Exhibits132: Sanofi SA - Business segments
Exhibits133: Sanofi SA - Key news
Exhibits134: Sanofi SA - Key offerings
Exhibits135: Sanofi SA - Segment focus
Exhibits136: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits137: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits138: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits139: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits140: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits141: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits142: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits143: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits144: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits145: Inclusions checklist
Exhibits146: Exclusions checklist
Exhibits147: Currency conversion rates for US$
Exhibits148: Research methodology
Exhibits149: Information sources
Exhibits150: Data validation
Exhibits151: Validation techniques employed for market sizing
Exhibits152: Data synthesis
Exhibits153: 360 degree market analysis
Exhibits154: List of abbreviations
